Compounds > 1-nitrohydroxyphenyl-n-benzoylalanine
Page last updated: 2024-09-05

1-nitrohydroxyphenyl-n-benzoylalanine and Lung Neoplasms

1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Baños, N; Cebrián, A; Cedeño, M; Corral, JM; Dómine, M; Galeano, C; García-Foncillas, J; Mahillo-Fernández, I; Puerto-Nevado, LD; Río-Vilariño, A1
Li, LJ; Xuan, JZ; Zheng, HN1

Other Studies

2 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and Lung Neoplasms

ArticleYear
Galectin-1, a novel promising target for outcome prediction and treatment in SCLC.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 156

    Topics: Benzamides; Galectin 1; Humans; Lung Neoplasms; Small Cell Lung Carcinoma

2022
Correlation of
    Clinical radiology, 2023, Volume: 78, Issue:7

    Topics: Adenocarcinoma of Lung; Biomarkers; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Tumor Burden; Tumor Microenvironment

2023